)
)
hVIVO Investor Relations Material
Latest events
H1 2024
hVIVO
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from hVIVO plc
Access all reports
hVIVO plc is a contract research organization (CRO) based in the United Kingdom, specializing in the testing of vaccines and antiviral treatments using human challenge clinical trials. The company is a global leader in this niche field, focusing on infectious and respiratory diseases. hVIVO works with major pharmaceutical companies, providing early clinical development services and testing products in areas like RSV, influenza, COVID-19, and other respiratory conditions. The company is headquartered in London, UK, and its shares are listed on the LSE.
Key slides for hVIVO plc
Latest articles
)
Prada: The Story of an Icon
Prada's journey from a small Milan boutique to a global luxury empire, led by Miuccia's innovation and creativity.
5 Dec 2024
)
Hims & Hers: Bridging Gaps in Telehealth
Hims & Hers was founded in 2016 by Andrew Dudum and has grown into a ~$4 billion company in the telehealth industry in less than a decade.
5 Dec 2024
)
Andrew Dudum: Founder and CEO of Hims & Hers
Andrew Dudum is the founder and CEO of Hims & Hers, an innovative telehealth company focused on bridging the gap between consumers and healthcare.
4 Dec 2024
Ticker symbol
HVO
Country
🇬🇧 United Kingdom